top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
3D Printing of Pharmaceuticals and Drug Delivery Devices
3D Printing of Pharmaceuticals and Drug Delivery Devices
Autore Lamprou Dimitrios A
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (436 p.)
Soggetto topico Medicine
Soggetto non controllato digital pharmacy
fused deposition modeling 3D printing
modified drug release
personalized medicines
telemedicine
three dimensional printing
additive manufacturing
3D printed drug products
printlets
personalised medicines
personalized pharmaceuticals
multiple units
spheroids
beads
acetaminophen
3D printing
fused filament fabrication
lignin
antioxidant materials
wound dressing
modified release
filament extrusion
fused layer modeling
theophylline
high API load
three-dimensional printing
fixed-dose combinations
tablets
multiple-layer dosage forms
stereolithography
vat polymerisation
fused deposition modeling
polylactic acid
chemical modification
MTT assay
biofilm formation
warfarin
semisolid extrusion 3D printing
inkjet printing
orodispersible film
oral powder
pediatric
hospital pharmacy
personalized medicine
on-demand manufacturing
drug delivery
micromedicine
drug development
micro-swimmer
micro-implant
oral dosages
microneedle
high-precision targeting
controlled release
geometry
resolution
feature size
release profile
vascularization
digital light processing technology
neural networks
optimization
prediction
FMD
pregabalin
gastric floating
complex structures
patient-specific
structural design
gums
Fused Deposition Modeling 3D Printing
processing parameters
pharmaceutical quality control
hot-melt extrusion
solid dosage forms
3D printed oral dosage forms
sustained drug release tablets
photopolymerization
paracetamol (acetaminophen)
aspirin (acetylsalicylic acid)
amorphous solid dispersion
poor solubility
fixed dose combination
stencil printing
pharmacoprinting
orodispersible discs
orodisperible films
floating systems
pulsatile release
chronotherapeutic delivery
wound-healing
3D bio-printing
pectin
propolis
cyclodextrin
3D bio-inks
fused deposition modelling
extrusion
vaginal meshes
mechanical properties
drug release
anti-infective devices
pelvic organ prolapse
stress urinary incontinence
gastro-retentive floating system
dissolution kinetics
implantable devices
subcutaneous
biodegradable
prolonged drug delivery
polymers
pharmaceuticals
extrusion-based 3D printing
fused deposition modeling (FDM)
pressure-assisted microsyringe (PAM)
materials
process
3D bioprinting
polymeric ink
pseudo-bone
implantable scaffold
computer-aided design (CAD) design
bioprinting
computer-aided design (CAD)
pharmaceutics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557780703321
Lamprou Dimitrios A  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato antibody drug conjugate (ADC)
PD-L1
tumor spheroid disruption
immune modulation
doxorubicin
graphene oxide
adsorption
cathepsin D
cathepsin L
anti-metastatic enzyme cancer therapy
nanoparticles
targeted delivery system
siRNA
osteopontin
mammary carcinoma
mesenchymal stem cells (MSCs)
TAT peptide
PLGA
paclitaxel
nano-engineered MSCs
orthotopic lung tumor model
intracranial glioma
immunotherapy
CPMV
viral nanoparticles
in situ vaccine
albumin nanoparticles
microbubble
ultrasound
theranostics
hepatocellular carcinoma
VX2 tumor
intra-arterial chemotherapy
lung cancer
nanomedicine
clinical status
cancer therapy
breast cancer
cell signaling
active targeting
passive targeting
EPR effect
oncogenes
nanoparticle
drug delivery
ligand
tumor targeting
biodistribution
Mesoporous silica nanoparticle
drug delivery system
target treatment
lanthanide metal
hyaluronic acid
hyaluronidase
drug combination
everolimus
dual-targeting
magnetic nanoparticles
monoclonal antibodies
nanostructured lipid carrier
platelet membrane
biomimicry
plasmonic photothermal therapy
gold nanorods
surgery
bleeding
dogs
cats
stimuli-responsive
DOX
SN38
CSCs
single-walled carbon nanotubes
chirality separation
NASH
drug-gene delivery
near IR hyperspectral imaging
plasmonics
copper
VEGF
glioblastoma
differentiated neuroblastoma
peptidomimetics
real-time quantitative polymerase chain reaction (qPCR)
actin
combinatorial therapy
anticancer and antibacterial activity
temoporfin
drug-in-cyclodextrin-in-liposome
hybrid nanoparticles
multicellular tumor spheroids
cyclodextrins
photodynamic therapy article
yet reasonably common within the subject discipline
antitumor strategy
biomimetic core–shell nanoparticles
NK cell-derived exosomes
folate receptor
albumin nanoparticle
microfluidic
cabazitaxel
polydopamine nanoparticles
size
cytotoxicity
iron affinity
FA-DABA-SMA
self-assembly
oncogenic proteins
intracellular disruption
folic receptor alpha
pancreatic cancer
parvifloron D
albumin
erlotinib
photodynamic therapy
lipid nanoparticles
tumor vectorization
verteporfin
ovarian carcinomatosis
spheroids
integrin
RGD peptide
cancer diagnosis
radiotherapy
hyperthermia therapy
biomimetic
nanocarrier
membrane-wrapped
cancer
targeted delivery
photothermal therapy
imaging
cancer nanomedicine
tumor microenvironment
nano–bio interactions
clinical translation
magnetic nanowires
magnetic hyperthermia
magnetic actuation
magnetic drug targeting
titanate nanotubes
gold nanoparticles
vectorization
colloidal stability
docetaxel
prostate cancer
mangiferin
anti-topoisomerase activity
extracellular vesicles
exosomes
chemico-physical functionalization
loading
translational medicine
nanotechnology: bioengineering
anacardic acid
mitoxantrone
targeted drug delivery
liposomes
melanoma
apoptosis
ascorbic acid
angiogenesis
epithelial-to-mesenchymal transition
hypoxia
immunosuppression
metabolism
nanotherapeutics
tumour microenvironment
DNA origami
liposome
remote loading
acute toxicity
organoids
magnetic silica-coated iron oxide nanochains
photothermal treatment
hyperthermia
collagen
cellular microenvironment
lymphadenectomy
magnetometer
sentinel lymph node dissection
SPION
superparamagnetic iron oxide nanoparticles
Vδ2 T cells
zoledronic acid
polymeric nanoconstruct
anti-tumor immunity
colorectal carcinoma
β-cyclodextrin nanosponges
BALB-neuT mice
brain tumours
glioma
blood brain barrier
polymeric nanoparticles
PEGylation
dioleoylphosphatidylethanolamine
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
folate
oxidation-sensitive release
cellular interaction
in vitro anti-cancer activity
triple negative breast cancer
organotin
mesoporous silica nanoparticles
MDA-MB-231
theranostic nanomaterials
nanobiotechnology
molecular imaging
nanosystems
nanomicelles
ovarian cancer
tumour targeting
chemotherapeutics
riboflavin
vitamin B2
nanomedicines
secondary structure
mixed micelle
pH responsive
targeted therapy
anti-cancer
shear stress
flow
in vitro
therapeutics
diagnostics
Immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes
Autore Ylostalo Joni H
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (204 p.)
Soggetto topico Medicine
Soggetto non controllato cell therapy
immunomodulation
polyunsaturated fatty acid
CD206
phagocytosis
mesenchymal stem cells
Vadadustat
AKB-6548
preconditioning
priming
secretome
chemotaxis
Wharton’s jelly mesenchymal stem cells
umbilical cord
oxygen conditions
secretory profile
neuroprotection
mesenchymal stromal cells
3D culture
neurospheres
spheroids
pluripotency
neural
quiescence
mesothelioma
malignant pleural mesothelioma (MPM)
liver cirrhosis
placenta-derived mesenchymal stem cells
WKYMVm
combination therapy
iPSC-derived MSCs
iMSC secretome
pre-conditioning
angiogenesis
IFN-γ
hypoxia
potentiation of iMSC efficacy
nanofiber-hydrogel composite
spinal cord injury
inflammation
macrophages
secondary injury
astrocytes
axon growth
adipose tissue-derived stem cells (ASCs)
autophagy
rapamycin
3-methyladenine
immunosuppression
exosome
engineered cardiac patches
adipose-derived stem cell
paracrine potential
osteogenic differentiation
hepatocyte growth factor
fibroblast growth factor 2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Enhancing Mesenchymal Stem Cells
Record Nr. UNINA-9910595079403321
Ylostalo Joni H  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside
Autore Tagit Oya
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (296 p.)
Soggetto topico Technology: general issues
History of engineering & technology
Materials science
Soggetto non controllato poly(lactic-co-glycolic acid) (PLGA)
blood–brain barrier (BBB)
current Good Manufacturing Practice (cGMP)
Food and Drug Administration (FDA)
nanotechnology
PLGA nanoparticles
neurodegenerative diseases
drug delivery
central nervous system
neuroprotective drugs
fluorescent labeling
DiI
coumarin 6
rhodamine 123
Cy5.5
quantum yield
brightness
stability of fluorescent label
confocal microscopy
intracellular internalization
in vivo neuroimaging
double-emulsion method
dry powder inhalation
antigen release
porous PLGA particles
microfluidics
methotrexate
chitosan
PLA/PLGA
sustained release
micro-implant
animal model
minimally invasive
drug delivery system
nanoparticles
poly (lactic-co-glycolic acid) (PLGA)
microfluidic
pharmacokinetics (PK) and biodistribution
atorvastatin calcium
poly(lactide-co-glycolide)
polymeric nanoparticles
carrageenan induced inflammation
anti-inflammatory
radiolabeled nanoparticles
nuclear medicine
photothermal therapy
phthalocyanine
SKOVip-kat
Katushka
TurboFP635
JO-4
PLGA
orthotopic tumors
3D culture
spheroids
poly(lactic-co-glycolic acid)
nanomedicine
scale-up manufacturing
clinical translation
inline sonication
tangential flow filtration
lyophilization
downstream processing
H. pylori
design of experiments
poly(lactic-co-glycolic) acid
size
cancer
chemoimmunotherapy
immunogenic cell death
immune checkpoint blockade
PNA5 glycopeptide
mas receptor
angiotensin
PLGA diblock copolymer
ester and acid-end capped
double emulsion solvent evaporation
biocompatible
biodegradable
cardiovascular
nanoparticle
solid-state characterization
in vitro
drug release kinetics modeling
PEGylation
amine
emulsion
polyvinyl alcohol (PVA)
Pluronic triblock copolymer
trehalose
sucrose
Indomethacin
solvents
stabilizers
morphology
particle-size
encapsulation
drug release
cytotoxicity
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease
Record Nr. UNINA-9910580215803321
Tagit Oya  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
Autore Pacak Karel
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (380 p.)
Soggetto non controllato polycythemia
peptide receptor radiotherapy
vasculogenesis
catecholamines
neuroendocrine
GTV
adaptive immunity
therapy resistance
histology
transgenic mice
cryoablation
spheroids
energy metabolism
somatostatinoma
angiogenesis
pheochromocytoma
SDHD
percutaneous ethanol injection
metanephrines
SDHB
global longitudinal strain
mutation
normetanephrines
catecholamine
PASS
PGL
177Lu-DOTATATE
chromosomal alteration
speckle-tracking echocardiography
lL-6
dog
percutaneous ablation
stem-like tumor cells
EPAS1
neural crest
fluorescence imaging
neutrophil
xenograft
inflammation
head and neck
weighted standard deviation
FGF21
calorimetry
HIF
average real variability
next-generation sequencing
adrenocortical carcinoma
carotid body
hypoxia-inducible factor
paraganglioma
succinate dehydrogenase
blood pressure variability
arrhythmia
mortality
NF1
toll-like receptor
GAPP
NET
subclinical systolic dysfunction
pheochromocytoma and paraganglioma
PET-CT
pan-cancer analysis
mouse pheochromocytoma cells
innate immunity
neurogenesis
neuroendocrine tumor
obesity
hypotension
hypoxia
CNV detection
18F-FDOPA
comparative genomics
adrenomedullary function
PCC
pathogen-associated molecular patterns
adrenal tumor
radiotherapy
11C-hydroxy-ephedrine
radiofrequency ablation
PPGL
minimally invasive procedure
sporadic
diabetes mellitus
adrenal incidentaloma
germline mutation
immunotherapy
VHL
immunohistochemistry
metastatic OR malignant pheochromocytoma
erythropoietin
postoperative
targeted therapy
PRRT
metastatic
mitochondria
T cell
TCA cycle
meta-analysis
pseudohypoxia
ectopic secretion
radiosensitization
chromogranin A
hereditary
hypertension
PET
phosphorylation tyrosine hydroxylase
ISBN 3-03921-655-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Pheochromocytoma
Record Nr. UNINA-9910367743903321
Pacak Karel  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui